Structural Intervention

About

Valve replacement surgery can be an effective, lifesaving treatment option for people with aortic or mitral valve diseases.

Aortic valve replacement is often required in older patients but the surgical risk is often extremely high. Transcatheter aortic valve implantation (TAVI) is an established therapy for intermediate and high surgical risk patients with symptomatic severe aortic valve stenosis.

Approximately 1.8% of the US population has mitral valve disease, and an estimated 106,000 surgeries per year are for the treatment of valvular heart disease. The durability of surgical mitral valve repairs and replacement are limited. There is a 25% rate of significant mitral regurgitation recurrence in surgical repairs at 2 years and a 44% rate of primary valvular failure at 15 years, leaving the patient with either symptomatic mitral regurgitation, stenosis or both.

Articles

Balloon Pre-dilation and Post-dilation in TAVR

Published:

12 October 2021

Citation:

Interventional Cardiology 2021;16:e28.

Patient-specific Computer Simulation of Bicuspid Aortic Valve

Published:

19 August 2021

Citation:

Interventional Cardiology 2021;16:e26.

Concomitant LV Outflow Tract Obstruction and Aortic Stenosis

Published:

10 June 2021

Citation:

Interventional Cardiology Review 2021;16:e11.

Valve-in-valve Procedure Using Cerebral Protection

Published:

02 February 2021

Citation:

Interventional Cardiology Review 2021;16(Suppl 1):1–4.